Content: This slide set summarizes WHO latest recommendations and considerations for choosing COVID-19 vaccine products with WHO Emergency Use List (EUL) (currently available under COVAX).
Objective: To help orient the Ministry of Health (MoH) and National Immunization Advisory Committee Group (NITAG) in their COVID-19 vaccine product choices to optimize their portfolio.
The information contained in this slide set is current as of 18 March 2022. It has been developed based on WHO SAGE Interim guidance documents, technical documents, briefs, and webpages. This slide set will be periodically updated.
You will need to be logged in to be able to post a reply. Login using the form on the right or register an account if you are new here. Register Here »
